Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;101:995-1001

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramanna, H.
Right arrow Articles by Robles de Medina, E. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramanna, H.
Right arrow Articles by Robles de Medina, E. O.
Related Collections
Right arrow Electrophysiology
Right arrow Arrhythmias, clinical electrophysiology, drugs

(Circulation. 2000;101:995.)
© 2000 American Heart Association, Inc.


Clinical Investigation and Reports

Identification of the Substrate of Atrial Vulnerability in Patients With Idiopathic Atrial Fibrillation

Hemanth Ramanna, MD; Richard N. W. Hauer, MD; Fred H. M. Wittkampf, PhD; Jacques M. T. de Bakker, PhD; Eric F. D. Wever, MD; Arif Elvan, MD; Etienne O. Robles de Medina, MD

From the Heart-Lung Institute (H.R., R.N.W.H., F.H.M.W., A.E., E.O.R.d.M.), University Medical Center Utrecht, Utrecht, the Netherlands; Interuniversity Cardiology Institute of the Netherlands (J.M.T.d.B.), Utrecht, the Netherlands; and St Antonius Hospital (E.F.D.W.), Nieuwegein, the Netherlands.

Correspondence to Hemanth Ramanna, MD, Heart-Lung Institute, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX Utrecht, the Netherlands.


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background—Experimental studies have shown that atrial fibrillation (AF) causes remodeling, which facilitates AF perpetuation. AF may also, however, occur in patients without remodeling and underlying structural cardiac disease. The substrate for enhanced vulnerability in these patients is unknown.

Methods and Results—We studied 43 patients without structural heart disease: 18 patients with documented sporadic paroxysmal AF and 25 control patients without AF. In each patient, a decapolar catheter was positioned against the right atrial free wall, and a quadripolar catheter was positioned in the right atrial appendage. Unipolar electrograms were recorded. Atrial vulnerability was assessed according to an increasingly aggressive stimulation protocol. Mean local fibrillatory interval (FI) was used as an index of local refractoriness. Spatial dispersion of refractoriness was assessed through the calculation of the coefficient of dispersion (CD), which was defined as the SD of mean local FI expressed as a percentage of the mean FI. In the AF group, AF was induced with a single extrastimulus in 16 of 18 patients; the CD was 5.4±2.6, and the mean FI was 164±29 ms. In the control group, AF could be induced only with more aggressive pacing in 23 of the 25 patients; the CD was 1.4±0.7 (P<0.0001), and the mean FI was 175±26 ms (NS).

Conclusions—Patients with idiopathic AF showed increased dispersion of refractoriness, which may be the substrate for the observed enhanced inducibility and spontaneous occurrence of AF.


Key Words: atrium • fibrillation • electrophysiology


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Atrial fibrillation (AF) may occur in patients without structural cardiac disease. In animal models, sustained AF causes remodeling of the atria, which facilitates AF perpetuation.1 2 In patients, however, AF may also occur without previous remodeling. The initiation of AF requires a trigger, which often is atrial tachycardia or atrial premature depolarizations.3 4 Not all patients with atrial arrhythmias, however, will develop AF; therefore, the presence of a trigger alone may not lead to AF. A substrate for atrial propensity to fibrillation (ie, atrial vulnerability) may also be required for AF initiation.

Atrial vulnerability may be increased in the presence of the dispersion of electrophysiological properties, as suggested on the basis of experimental data.5 6 With the use of epicardial multielectrode recordings during cardiac surgery, Ramdat Misier et al7 found increased dispersion of refractoriness and shortened refractory periods in patients with idiopathic AF compared with control patients. However, these patients had frequent AF episodes, so it is unclear whether the observed electrophysiological changes in dispersion were the cause or the result of AF.

The aim of the present study was to assess whether patients with idiopathic paroxysmal AF without electrophysiological remodeling have specific atrial electrophysiological properties that might increase the propensity to AF in comparison with control subjects.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Patients
A total of 245 patients (age <60 years) undergoing an electrophysiological study at the Heart-Lung Institute for supraventricular tachycardia were screened for inclusion on the basis of the criteria listed in Table 1Down. Informed consent was obtained from the patients, and the study was approved by the hospital review board. All patients had a physical examination and underwent ECG, echocardiography, and biochemical and hematological testing to exclude structural heart disease and conditions with potential effects on cardiac hemodynamic or electrophysiological functions. Telemetry was performed for >=24 hours before the electrophysiological study. Of these 245 patients, 23 had prior documented AF, 4 were excluded due to an abnormal echocardiogram, and 1 was excluded due to alcoholism. Thus, 18 patients with AF remained, and they were assigned to the AF group. Of the patients without AF, 25 were randomly selected and assigned to the control group. The study was carried out during the routine electrophysiological investigation before catheter ablation of the tachycardia.


View this table:
[in this window]
[in a new window]
 
Table 1. Inclusion and Exclusion Criteria

AF Group
The 18 patients in the AF group (15 men and 3 women, mean age 33.1±9.2 years, maximum age 46 years) had prior paroxysmal AF episodes. ECG documentation of >=1 episode was required for inclusion in the study, and each patient was specifically questioned about the duration and onset of previous episodes. All patients were able to distinguish AF episodes from their regular supraventricular tachycardia. A rapid irregular heartbeat was interpreted as an AF episode. These patients had experienced a median of 1 (mean 1.8, SD 2.5, range 1 to 12) episode of AF with a median duration of 1 hour (range 0.25 to 4 hours). The last spontaneous symptomatic episode of AF preceded the electrophysiological study by a median of 162 days (range 6 to 529 days). None of the patients had AF episodes during the telemetric observation period. In this group, all patients had an accessory atrioventricular pathway, of which 2 were concealed (pathway location: 12 left free wall, 2 left posteroseptal, 2 right posteroseptal, 1 right anteroseptal, and 1 parahisian).

Control Group
The 25 control patients (17 men and 8 women, mean age 33.5±11.0 years, maximum age 52 years) did not have a history of AF or episodes of irregular heartbeat. There were 18 patients with accessory pathways, of which 2 were concealed (accessory pathway location: 14 left free wall, 1 left posteroseptal, 2 right free wall, and 1 parahisian), and 7 patients with atrioventricular nodal reentrant tachycardia (AVNRT). Telemetry did not reveal any AF episodes.

Study Protocol
All patients were studied in the fasting, nonsedated state. After right femoral venous access was obtained, 2 electrode catheters (electrode spacing 5 mm) were positioned in the right atrium, a decapolar catheter (Bard USCI) was positioned at the lateral free wall, and a quadripolar catheter (Bard USCI) was positioned in the appendage as shown (Figure 1Down). The position of the decapolar catheter was selected to maximize the number of electrodes with good tissue contact and to minimize the effects of far-field interference from ventricular activity on the unipolar electrogram. The catheters were repositioned until a stable position with >=8 unipolar electrograms of >0.5 mV was obtained during sinus rhythm. Twelve unipolar electrograms were recorded (gain 2 mV/cm, filter 0.05 to 500 Hz) (10 from the decapolar and 2 from the proximal pair of the quadripolar catheter) with the use of an electrophysiological recording system (Cardiolab; Prucka Engineering).



View larger version (118K):
[in this window]
[in a new window]
 
Figure 1. Fluoroscopic image in anteroposterior projection showing decapolar catheter at right atrial lateral free wall and quadripolar catheter in right atrial appendage. Decapolar catheter position was consistent in all patients and was designed to maximize number of electrodes with firm wall contact and to maintain catheter stability for duration of study protocol. In addition, ventricular far field interference in unipolar electrograms was minimized with the use of this position.

The inducibility of AF was assessed through programmed stimulation with the use of unipolar cathodal pacing (pulse width 2 ms). Pacing consisted of a 4-stage, progressively aggressive stimulation protocol to achieve AF with a duration of >=1 minute. Stage 1 consisted of pacing at twice diastolic threshold current with an 8-pulse drive train and 1 extrastimulus starting at the tip electrode of the decapolar catheter. The extrastimulus interval S1S2 of 100 ms was incremented in steps of 5 ms until atrial capture occurred. If AF with duration of >1 minute was not obtained in this manner, stage 1 was successively repeated at all of the other electrodes. If AF was not induced, the next stage was performed. Stage 2 consisted of pacing at 4 times diastolic threshold current with an 8-pulse drive train and 1 extrastimulus from the tip electrode of the quadripolar catheter. Stage 3 was the same as stage 2 but with 2 extrastimuli. Stage 4 consisted of multiple 5-second ramp bursts at a cycle length of 100 to 50 ms at 4 times diastolic threshold current from the tip electrode of the quadripolar catheter. Other induced types of tachycardia were pace terminated immediately, and the pacing protocol was interrupted for 1 minute after these episodes as well as after AF episodes that lasted for <1 minute. For this study, AF with a duration of >1 minute was considered sustained AF. If AF persisted beyond 5 minutes, electrical cardioversion was performed.

Data Analysis
The segment between 15 and 30 seconds after AF onset was used for electrogram analysis. Fibrillation intervals were measured through the detection of the intrinsic negative deflections with negative slopes of >0.5 mV/s.7 For each recording site, histograms of fibrillatory intervals were plotted. Undersensing of intrinsic deflections, resulting in multiples of fibrillatory intervals, was detected through the observation of secondary peaks in the histogram. Such intervals were discarded, as described by Opthof et al.8 For each recording site, the sum of all discarded intervals was calculated. If this sum exceeded 4 seconds, the electrogram recording site was excluded from further analysis.

The mean fibrillatory intervals were calculated for each site to serve as an index for the local refractory period.9 The average and SD values of these indices were calculated. Spatial dispersion was defined as the coefficient of dispersion (CD) and calculated as the SD of the mean fibrillatory intervals expressed as a percentage of the mean fibrillatory interval: [(SDx100)/mean fibrillatory interval].7

Statistical Analysis
The AF group was compared with the control group. Categorical variables were compared with the use of the {chi}2 test, and mean values were compared with the use of Student’s t test. A probability value of 0.05 was considered statistically significant.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
The measurement of fibrillatory intervals resulted in histograms such as that shown in Figure 2Down. The mean fibrillatory intervals detected at all recording sites were displayed as shown in Figure 3Down. The range of local mean fibrillatory intervals indicates the spatial dispersion measured in 1 patient. It is readily observed that in the patient with prior AF, there is more spatial dispersion of mean fibrillatory intervals than in the control patient without AF (Figure 3Down).



View larger version (15K):
[in this window]
[in a new window]
 
Figure 2. Histogram of mean fibrillatory intervals at a single atrial recording site. Intervals have been grouped into 10-ms bins. There is a large peak at 150 ms and a small peak at 300 ms. Intervals related to secondary peak, caused by undetected intrinsic deflections, were discarded. Mean fibrillatory interval at this recording site was defined as average of intervals in first peak: in this case, 154 ms. This mean fibrillatory interval was used as an index for local refractoriness.



View larger version (25K):
[in this window]
[in a new window]
 
Figure 3. Mean fibrillatory intervals (in ms) for each measurable atrial recording site in a typical patient (patient 17) with prior paroxysmal AF (A) and in a control patient (patient 11) (B). Patient with prior AF has more inhomogeneity of mean fibrillatory intervals than does control patient. AF could be induced with a single extrastimulus in patient with AF; in control patient, it was induced with burst pacing only. *Electrodes marked had inadequate signal quality and thus were excluded from analysis.

AF Group
Baseline data are given in Table 2Down. AF was induced with a single extrastimulus at twice diastolic threshold current in 16 of 18 patients. In the other 2 patients, only nonsustained AF episodes (2 per patient) could be induced, with a mean duration of 28±4.5 seconds; more aggressive pacing was required to obtain sustained AF. Adequate recordings with a <4-second dropout were obtained from an average of 9 (range 7 to 11) electrodes per patient. Of these 15-second recordings, a mean of 1.16 (range 0.15 to 2.70) seconds were excluded due to inadequate dV/dt.


View this table:
[in this window]
[in a new window]
 
Table 2. Baseline and Electrophysiological Parameters of AF Group

The mean number of measured fibrillatory intervals per recording site was 85±20. The overall mean CD value for the AF group was 5.4±2.6, and the overall mean fibrillatory interval was 164±29 ms. In 3 patients, the mean fibrillatory interval was between 200 and 225 ms. However, the irregularity and polymorphic character of the electrograms, with cycle length variations of >=20% of the mean cycle length, were compatible with AF.

Control Group
The baseline and electrophysiological parameters of the control patients are given in Table 3Down. Sustained AF was induced with a single extrastimulus at twice diastolic threshold current in only 2 of 25 patients. Nonsustained AF could be induced in an additional 2 patients (2 and 3 episodes, mean duration 17±5.2 seconds). In these 2 and the remaining 21 patients, more aggressive pacing was required to obtain sustained AF, with 17 patients requiring burst pacing at 4 times diastolic threshold. Adequate recordings with <4-second dropout were obtained from an average of 9 (range 8 to 12) electrodes per patient. Of these 15-second recordings, a mean of 1.62 (range 0.14 to 2.91) seconds were excluded due to inadequate dV/dt.


View this table:
[in this window]
[in a new window]
 
Table 3. Baseline and Electrophysiological Parameters of Control Group

The mean number of measured fibrillatory intervals per recording site was 80±24. The overall mean CD value for the control group was 1.4±0.7, and the overall mean fibrillatory interval was 175±26 ms. In 4 patients, the mean fibrillatory interval was between 200 and 225 ms. However, the irregularity and polymorphic character of the electrograms, with cycle length variations of >=20% of the mean cycle length, were compatible with AF.

In the control group, the patients with Wolff-Parkinson-White (WPW) syndrome had a mean CD value of 1.4±0.6 and an overall mean fibrillatory interval of 173±27 ms. In the patients with AVNRT, these values were 1.5±1.0 and 182±27 ms, respectively. These subgroups did not differ significantly.

Comparison Between AF and Control Groups
The electrophysiological parameters are given in Table 4Down. There were no significant differences in left atrial dimensions, baseline heart rate, and pacing thresholds. AF was induced more easily, with 1 extrastimulus, in the AF group than in the control group (P<0.0001), as shown in Figure 4Down. The average CD value was significantly higher in the AF group than in the control group with only minimal overlap (P<0.0001), as shown in Figure 5ADown.


View this table:
[in this window]
[in a new window]
 
Table 4. Statistical Analysis



View larger version (29K):
[in this window]
[in a new window]
 
Figure 4. The inducibility of AF was assessed by performing a 4-stage pacing protocol. Number of patients in AF and control groups have been displayed per stage. 1 ES 2x DTC indicates that sustained AF could be induced with a drive train (Cl 500) and 1 extrastimulus at twice diastolic threshold current (DTC); 1 ES 4x DTC, drive train and 1 extrastimulus at 4 times DTC; 2 ES 4x DTC, drive train and 2 extrastimuli at 4 times DTC; and burst indicates that AF could only be induced using high-frequency burst pacing. It is readily observed that AF was induced much more easily in AF group than in control group.



View larger version (16K):
[in this window]
[in a new window]
 
Figure 5. A, CD for all patients in both groups; mean values are indicated by horizontal lines. Patients with prior paroxysmal AF had significantly higher CDs than control patients. B, Overall mean fibrillatory intervals (in ms) of all patients in AF group versus control group; mean values are indicated by horizontal lines. There was no statistically significant difference in mean fibrillatory interval between both groups.

Mean fibrillatory intervals did not differ significantly between the groups (P=0.17), as shown in Figure 5BUp. The shortest preexcited RR interval (ie, refractoriness of accessory pathway) and the average heart rate during AF did not differ between the groups.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
In the present study, patients without demonstrable structural heart disease and with short-lasting and infrequent symptomatic episodes of AF had increased spatial dispersion of refractoriness. This increased dispersion could not be attributed to electrical remodeling because most patients had experienced only a single, short symptomatic episode of AF that occurred a long time (median 162 days, minimum 6 days) before the electrophysiological study. Telemetric monitoring also did not reveal any asymptomatic episodes for >=24 hours before the study. In addition, in the AF group, the mean fibrillatory intervals were not significantly shorter than those in the control group. The increased dispersion of refractoriness was associated with enhanced atrial inducibility of AF, as would be expected on the basis of experimental findings.5 10 Increased dispersion of refractoriness thus may be a major predisposing factor for the initiation of AF.

Dispersion and Remodeling
Several recent experimental studies in animals have shown that AF causes shortening of refractoriness,1 2 10 11 an increase in atrial inducibility of AF,1 10 and an increase in dispersion of refractoriness.10 11 With the use of intraoperative epicardial recordings, Ramdat Misier et al7 found increased spatial dispersion of refractoriness in patients undergoing surgery for AF. These patients had frequent symptomatic AF episodes for which they were undergoing surgery, and the time from the last AF episode to the measurements was not known. It is conceivable that these patients had long-standing AF that caused atrial remodeling, as suggested by their significantly shorter average fibrillatory intervals.1 2 Thus, on the basis of their study, it was unclear whether the increased dispersion was the cause or the result of AF. These mentioned findings in experimental models1 2 10 11 and in patients7 underlie the importance of the exclusion of the effects of remodeling when studying the propensity for AF at an early stage of idiopathic AF.

Substrate for Increased Dispersion
The pathophysiology of the increased dispersion of refractoriness is not known. Atrial fibrosis, as found in structural heart disease and in the elderly,12 may give rise to electrical inhomogeneity. Our patients did not have identifiable structural heart disease, and their mean age was 33 years. Atrial dilatation may be another causative factor,13 but echocardiography did not demonstrate atrial enlargement in our patients and Doppler-derived measurements did not show increased atrial pressure. Inhomogeneity of autonomic innervation may be another mechanism for increased dispersion of refractoriness as shown by Olgin et al14 in a canine model of sympathetic denervation.

AF and WPW Syndrome
Most of the patients in the present study had WPW syndrome. Branched accessory pathways causing microreentry have been suggested as causative factors for AF. Fujimura et al15 found that in patients with WPW syndrome, AF usually was initiated in the right atrium regardless of accessory pathway location. In addition, Wathen et al16 did not find any changes in atrial electrophysiological properties after accessory pathway ablation. In our study, the measurements and induction of AF were performed in the right atrium, whereas the accessory pathway was left-sided in most patients (AF group: 14 of 18, control group: 15 of 18). Moreover, the control group included a large number of patients who also had WPW syndrome. These patients had low dispersion and low inducibility despite their accessory pathway. The anterograde refractory period of the accessory pathway did not differ significantly between these patients and those in the AF group, and the average heart rate during AF was comparable. Therefore, a hemodynamic cause for the difference in dispersion between these patients seems unlikely. In addition, we studied control patients with AVNRT (ie, without an atrioventricular bypass tract). Dispersion in these patients did not differ from that in control patients with WPW syndrome. The results of our study suggest that in patients with prior paroxysmal AF, the atria had abnormal electrophysiological properties that could not be directly attributed to the accessory pathway.

Study Limitations
In the AF group, the incidence of AF episodes was quantified through questioning of patients about symptoms of irregular heartbeat. Asymptomatic AF episodes therefore could not be entirely excluded. In the AF group, however, 16 of 18 patients also had preexcitation and rapid ventricular rates during AF. Therefore, in this subset of patients, AF episodes would be more likely to cause symptoms than they would in the general population. In addition, AF (symptomatic or asymptomatic) during the 24-hour period before the study was excluded through the use of telemetric monitoring.

One may question the use of mean fibrillatory intervals as the most appropriate method to estimate local refractoriness. Previous experimental studies by Allessie et al17 have demonstrated an excitable gap during AF. Nevertheless, several studies have demonstrated a strong correlation between local refractory period as measured with extrastimuli and the local mean fibrillatory interval.7 9 18 19

Data were obtained from a small portion of the right atrium with a relatively limited number of electrodes. The septum and left atrium were not investigated. In 3 AF patients, the CD value was within the normal range (<=3.0). This may be due to catheter positioning; dispersion may have been increased at other positions.

Conclusions
Patients with idiopathic AF had increased spatial dispersion of refractoriness unrelated to electrical remodeling. This increased dispersion appeared to be the substrate for the enhanced atrial vulnerability.

Received July 12, 1999; revision received September 21, 1999; accepted October 7, 1999.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 

  1. Wijffels MC, Kirchhof CJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: a study in awake chronically instrumented goats. Circulation. 1995;92:1954–1968.[Abstract/Free Full Text]
  2. Goette A, Honeycutt C, Langberg JJ. Electrical remodeling in atrial fibrillation: time course and mechanisms. Circulation. 1996;94:2968–2974.[Abstract/Free Full Text]
  3. Jaïs P, Haïssaguerre M, Shah DC, Chouairi S, Gencel L, Hocini M, Clementy J. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation. 1997;95:572–576.[Abstract/Free Full Text]
  4. Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou C, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659–666.[Abstract/Free Full Text]
  5. Allessie MA, Bonke FIM, Schopman FJG. Circus movement in rabbit atrial muscle as a mechanism of tachycardia, II: the role of nonuniform recovery of excitability in the occurrence of unidirectional block, as studied with multiple multielectrodes. Circ Res. 1976;2:168–178.
  6. Spach MS, Dolber PC, Heidlage JF. Interactions of inhomogeneities of repolarization with anisotropic propagation in dog atria: a mechanism for both preventing and initiating re-entry. Circ Res. 1989;65:1612–1631.[Abstract/Free Full Text]
  7. Ramdat Misier A, Opthof T, van Hemel NM, Defauw JJ, de Bakker JM, Janse MJ, van Capelle FJ. Increased dispersion of "refractoriness" in patients with idiopathic paroxysmal atrial fibrillation. J Am Coll Cardiol. 1992;19:1531–1535.[Abstract]
  8. Opthof T, Ramdat Misier A, Coronel R, Vermeulen JT, Verberne HJ, Frank RG, Moulijn AC, van Capelle FJ, Janse MJ. Dispersion of refractoriness in canine ventricular myocardium: effects of sympathetic stimulation. Circ Res. 1991;68:1204–1215.[Abstract/Free Full Text]
  9. Lammers WEJP, Schalij MJ, Kirchoff CJHJ, Allessie MA. Quantification of spatial inhomogeneity in conduction and initiation of reentrant atrial arrhythmias. Am J Physiol. 1990;28:H1254–H1263.
  10. Fareh S, Villemare C, Nattel S. Importance of refractoriness heterogeneity in the enhanced vulnerability to atrial fibrillation induction caused by tachycardia-induced atrial electrical remodeling. Circulation. 1998;98:2202–2209.[Abstract/Free Full Text]
  11. Gaspo R, Bosch RF, Talajic M, Nattel S. Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model. Circulation. 1997;96:4027–4035.[Abstract/Free Full Text]
  12. Spach MS, Dolber P. Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscle: evidence for electrical uncoupling of side to side fiber connections with increasing age. Circ Res. 1987;60:206–219.[Abstract/Free Full Text]
  13. Ravelli F, Allessie MA. Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart. Circulation. 1997;96:1686–1695.[Abstract/Free Full Text]
  14. Olgin JE, Sih HJ, Hanish S, Jayachandran V, Wu J, Zheng H, Winkle W, Mullholland GK, Zipes DP, Hutchins G. Heterogeneous atrial denervation creates substrate for sustained atrial fibrillation. Circulation. 1998;98:2608–2614.[Abstract/Free Full Text]
  15. Fujimura O, Klein GJ, Yee R, Sharma AD. Mode of onset of atrial fibrillation in the Wolff-Parkinson-White syndrome: how important is the accessory pathway. J Am Coll Cardiol. 1990;15:1082–1088.[Abstract]
  16. Wathen M, Natale A, Wolfe K, Yee R, Klein GJ. Initiation of atrial fibrillation in the Wolff-Parkinson-White syndrome: the importance of the accessory pathway. Am Heart J. 1993;125:753–759.[Medline] [Order article via Infotrieve]
  17. Allessie MA, Kirchoff CJHJ, Scheffer GJ, Chorro FJ, Brugada J. Regional control of atrial fibrillation by rapid pacing in conscious dogs. Circulation. 1991;84:1689–1697.[Abstract/Free Full Text]
  18. Kim KB, Rodefeld MD, Schuessler RB, Cox JL, Boineau JP. Relationship between local atrial fibrillation interval and refractory period in the isolated canine atrium. Circulation. 1996;94:2961–2967.[Abstract/Free Full Text]
  19. Capucci A, Biffi M, Boriani G, Ravelli F, Nollo G, Sabbatani P, Orsi C, Magnani B. Dynamic electrophysiological behaviour of human atria during paroxysmal atrial fibrillation. Circulation. 1995;92:1193–1202.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
EuropaceHome page
K. A. Hafid, H. C. Xin, W. Xi, Z. Q. Yan, and Y. Bo
Difference between electrical remodelling after pulmonary veins and right atrium appendage pacing
Europace, July 13, 2007; (2007) eum108v1.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
Writing Committee Members, V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, et al.
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society
Europace, September 1, 2006; 8(9): 651 - 745.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
J. Am. Coll. Cardiol., August 15, 2006; 48(4): e149 - e246.
[Full Text] [PDF]


Home page
CirculationHome page
V. Fuster, L. E. Ryden, D. S. Cannom, H. J. Crijns, A. B. Curtis, K. A. Ellenbogen, J. L. Halperin, J.-Y. Le Heuzey, G. N. Kay, J. E. Lowe, et al.
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society
Circulation, August 15, 2006; 114(7): e257 - e354.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. Takahashi, P. Jais, M. Hocini, P. Sanders, M. Rotter, T. Rostock, L.-F. Hsu, F. Sacher, J. Clementy, and M. Haissaguerre
Shortening of Fibrillatory Cycle Length in the Pulmonary Vein During Vagal Excitation
J. Am. Coll. Cardiol., February 21, 2006; 47(4): 774 - 780.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
J. J.H. Chong, S. Kumar, L. Thomas, and S. Thomas
Supraventricular ectopy and recurrence of atrial fibrillation after electrical cardioversion.
Europace, January 1, 2006; 8(5): 341 - 344.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Firouzi, H. Ramanna, B. Kok, H. J. Jongsma, B. P.C. Koeleman, P. A. Doevendans, W. A. Groenewegen, and R. N.W. Hauer
Association of Human Connexin40 Gene Polymorphisms With Atrial Vulnerability as a Risk Factor for Idiopathic Atrial Fibrillation
Circ. Res., August 20, 2004; 95(4): e29 - e33.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. J.J.M Brundel, H. H Kampinga, and R. H Henning
Calpain inhibition prevents pacing-induced cellular remodeling in a HL-1 myocyte model for atrial fibrillation
Cardiovasc Res, June 1, 2004; 62(3): 521 - 528.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
B. Gorenek, G. Kudaiberdieva, O. Goktekin, Y. Cavusoglu, A. Birdane, A. Unalir, N. Ata, and B. Timuralp
Long-short sequence may predict immediate recurrence of atrial fibrillation after external cardioversion
Europace, January 1, 2003; 5(1): 11 - 16.
[Abstract] [PDF]


Home page
EuropaceHome page
E. R. Jessurun, J. M. T. de Bakker, N. M. van Hemel, T. Opthof, A. C. Linnenbank, P. F. H. M. van Dessel, J. J. A. M. T. Defauw, and A. B. de la Riviere
Right atrial modification of maze surgery does not affect refractoriness and conduction patterns of human lone atrial fibrillation
Europace, January 1, 2003; 5(1): 39 - 46.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
H. Morita, K. Kusano-Fukushima, S. Nagase, Y. Fujimoto, K. Hisamatsu, H. Fujio, K. Haraoka, M. Kobayashi, S. T. Morita, K. Nakamura, et al.
Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome
J. Am. Coll. Cardiol., October 16, 2002; 40(8): 1437 - 1444.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Shimizu and O. A. Centurion
Electrophysiological properties of the human atrium in atrial fibrillation
Cardiovasc Res, May 1, 2002; 54(2): 302 - 314.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. J.J.M. Brundel, R. H. Henning, H. H. Kampinga, I. C. Van Gelder, and H. J.G.M. Crijns
Molecular mechanisms of remodeling in human atrial fibrillation
Cardiovasc Res, May 1, 2002; 54(2): 315 - 324.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
B. J.J.M Brundel, J. Ausma, I. C van Gelder, J. J.L Van Der Want, W. H van Gilst, H. J.G.M Crijns, and R. H Henning
Activation of proteolysis by calpains and structural changes in human paroxysmal and persistent atrial fibrillation
Cardiovasc Res, May 1, 2002; 54(2): 380 - 389.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
S.P Fynn, D.M Todd, W.J.C Hobbs, K.L Armstrong, and C.J Garratt
Role of dispersion of atrial refractoriness in the recurrence of clinical atrial fibrillation. A manifestation of atrial electrical remodelling in humans?
Eur. Heart J., October 1, 2001; 22(19): 1822 - 1834.
[Abstract] [PDF]


Home page
J Am Coll CardiolHome page
H. Ramanna, A. Elvan, F. H. M. Wittkampf, J. M. T. de Bakker, R. N. W. Hauer, and E. O. Robles de Medina
Increased dispersion and shortened refractoriness caused by verapamil in chronic atrial fibrillation
J. Am. Coll. Cardiol., April 1, 2001; 37(5): 1403 - 1407.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
Z. Li, E. Hertervig, S. Yuan, Y. Yang, Z. Lin, and S. B. Olsson
Dispersion of atrial repolarization in patients with paroxysmal atrial fibrillation
Europace, January 1, 2001; 3(4): 285 - 291.
[Abstract] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramanna, H.
Right arrow Articles by Robles de Medina, E. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramanna, H.
Right arrow Articles by Robles de Medina, E. O.
Related Collections
Right arrow Electrophysiology
Right arrow Arrhythmias, clinical electrophysiology, drugs